Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial
Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page
- Check5 days agoChange DetectedThe history shows a new site revision (v3.6.5) was added and the previous revision (v3.6.4) was removed, reflecting a minor system update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new version entry, Revision: v3.6.4, appears in the history, replacing the prior Revision: v3.6.3. This reflects a minor update to the record's versioning on the page.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new release entry, Revision: v3.6.3, has been added to the study record's version history, following the previous Revision: v3.6.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study history now includes a new revision entry v3.6.2 and removes the older v3.6.0 from the visible history. This updates the version record shown on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study is no longer looking for participants, indicating enrollment has halted. The history also shows a new revision labeled v3.6.0 and the previous revision v3.5.5 has been removed from the record history.SummaryDifference0.6%

- Check69 days agoChange DetectedA new revision entry v3.5.5 was added to the record history to replace the previous revision v3.5.4, indicating an update to the study record.SummaryDifference0.1%

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.